VEGFA and neoplasm: Both PI13K and AKT are activated by interleukin (IL-12, I-L15), oncogenes, vascular endothelial growth factor (VEGF), and cytomegalovirus, which activates mTOR leading to the proliferation of lymphocytes, tumor cells, cytomegalovirus, and endothelial cells.